Long Covid is a complex, multisystemic condition that affects people of all ages and backgrounds, with a wide range of symptoms and potential subtypes. It can develop after mild or severe SARS-CoV-2 infections and is associated with increased risk of chronic disease. Research has identified multiple potential pathogenic mechanisms, including viral persistence, autoimmune responses, mitochondrial dysfunction, vascular inflammation, and microbiome dysbiosis. Despite progress in understanding Long Covid, prevention efforts have stalled, and there is uncertainty about long-term government commitment to research. Currently, no treatment has been validated through randomized controlled trials. Vaccination and antiviral treatments have shown promise in reducing the risk of Long Covid, with vaccines reducing risk by 15-75% and antivirals like nirmatrelvir and molnupiravir showing some effectiveness. However, more research is needed, especially in younger and healthier individuals. Reinfection increases the risk of Long Covid, and studies suggest that multiple infections may lead to higher risk. Long Covid can have long-term health effects, including chronic diseases and reduced quality of life, and may impact life expectancy. The care needs of Long Covid patients are often unmet, with many facing skepticism and dismissal of their symptoms. There is a need for better healthcare systems, training for healthcare providers, and improved access to care. There is also a need for consensus on definitions and clinical trial endpoints for Long Covid to facilitate research. Long Covid is a heterogeneous condition, and a single biomarker is unlikely to explain its complexity. Artificial intelligence may help develop multidimensional biomarkers for different subtypes. Preventing infections and reinfections is the best way to prevent Long Covid. Non-pharmaceutical interventions, such as masking and improved air quality, are essential. Developing more durable vaccines and antivirals is also needed. Research into infection-associated chronic diseases is important, as many pathogens can cause long-term health effects. Addressing Long Covid requires continued focus on prevention, treatment, and research. The world must rise to the challenge of Long Covid to protect the health and well-being of current and future generations.Long Covid is a complex, multisystemic condition that affects people of all ages and backgrounds, with a wide range of symptoms and potential subtypes. It can develop after mild or severe SARS-CoV-2 infections and is associated with increased risk of chronic disease. Research has identified multiple potential pathogenic mechanisms, including viral persistence, autoimmune responses, mitochondrial dysfunction, vascular inflammation, and microbiome dysbiosis. Despite progress in understanding Long Covid, prevention efforts have stalled, and there is uncertainty about long-term government commitment to research. Currently, no treatment has been validated through randomized controlled trials. Vaccination and antiviral treatments have shown promise in reducing the risk of Long Covid, with vaccines reducing risk by 15-75% and antivirals like nirmatrelvir and molnupiravir showing some effectiveness. However, more research is needed, especially in younger and healthier individuals. Reinfection increases the risk of Long Covid, and studies suggest that multiple infections may lead to higher risk. Long Covid can have long-term health effects, including chronic diseases and reduced quality of life, and may impact life expectancy. The care needs of Long Covid patients are often unmet, with many facing skepticism and dismissal of their symptoms. There is a need for better healthcare systems, training for healthcare providers, and improved access to care. There is also a need for consensus on definitions and clinical trial endpoints for Long Covid to facilitate research. Long Covid is a heterogeneous condition, and a single biomarker is unlikely to explain its complexity. Artificial intelligence may help develop multidimensional biomarkers for different subtypes. Preventing infections and reinfections is the best way to prevent Long Covid. Non-pharmaceutical interventions, such as masking and improved air quality, are essential. Developing more durable vaccines and antivirals is also needed. Research into infection-associated chronic diseases is important, as many pathogens can cause long-term health effects. Addressing Long Covid requires continued focus on prevention, treatment, and research. The world must rise to the challenge of Long Covid to protect the health and well-being of current and future generations.